BONST
CVS icon

Bank of Nova Scotia Trust’s CVS Health CVS Stock Holding History

Bank of Nova Scotia Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,602
Closed -$208K – 138
2024
Q1 		$208K Buy
+2,602
New +$199K 0.02% 133
2023
Q2 		– Sell
-2,713
Closed -$202K – 140
2023
Q1 		$202K Buy
2,713
+485
+22% +$40.7K 0.02% 134
2022
Q4 		$208K Hold
2,228
– – 0.02% 134
2022
Q3 		$212K Buy
+2,228
New +$221K 0.02% 127
2018
Q4 		– Sell
-2,790
Closed -$220K – 118
2018
Q3 		$220K Buy
+2,790
New +$199K 0.02% 117
2018
Q2 		– Sell
-4,175
Closed -$260K – 124
2018
Q1 		$260K Sell
4,175
-5,432
-57% -$390K 0.03% 106
2017
Q4 		$697K Sell
9,607
-35,753
-79% -$2.6M 0.08% 75
2017
Q3 		$3.69M Sell
45,360
-38,577
-46% -$3.05M 0.39% 51
2017
Q2 		$6.75M Sell
83,937
-811
-1% -$64K 0.77% 32
2017
Q1 		$6.65M Buy
84,748
+2,163
+3% +$173K 0.75% 31
2016
Q4 		$6.52M Buy
82,585
+15,428
+23% +$1.25M 0.75% 30
2016
Q3 		$5.98M Buy
67,157
+29,171
+77% +$2.75M 0.71% 33
2016
Q2 		$3.64M Sell
37,986
-1,238
-3% -$123K 0.48% 40
2016
Q1 		$4.07M Sell
39,224
-507
-1% -$49.3K 0.55% 42
2015
Q4 		$3.88M Sell
39,731
-1,177
-3% -$115K 0.58% 41
2015
Q3 		$3.95M Buy
40,908
+1,540
+4% +$162K 0.55% 42
2015
Q2 		$4.16M Sell
39,368
-1,080
-3% -$110K 0.53% 41
2015
Q1 		$4.17M Sell
40,448
-136
-0.3% -$13.8K 0.54% 44
2014
Q4 		$3.91M Buy
40,584
+348
+0.9% +$30.7K 0.47% 42
2014
Q3 		$3.2M Sell
40,236
-3,287
-8% -$259K 0.37% 47
2014
Q2 		$3.31M Sell
43,523
-3,860
-8% -$292K 0.36% 49
2014
Q1 		$3.55M Sell
47,383
-2,137
-4% -$151K 0.47% 42
2013
Q4 		$3.54M Sell
49,520
-3,785
-7% -$243K 0.48% 42
2013
Q3 		$3.02M Sell
53,305
-2,265
-4% -$135K 0.43% 44
2013
Q2 		$3.34M Buy
+55,570
New +$3.22M 0.49% 37

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of Nova Scotia Trust's CVS Position: Q2 2024 in Review

Bank of Nova Scotia Trust sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,602 shares — an estimated $208K sold.

Bank of Nova Scotia Trust first reported a position in CVS in Q2 2013 and held it in 25 quarters. The position peaked at $6.75M in Q2 2017. 1,915 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Bank of Nova Scotia Trust reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 2,602 CVS Health shares in Q2 2024, an estimated $208K.
  • Bank of Nova Scotia Trust first reported a position in CVS Health in Q2 2013 and held it in 25 quarters.
  • Bank of Nova Scotia Trust's CVS Health position peaked at $6.75M in Q2 2017.
  • 1,915 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Bank of Nova Scotia Trust's 13F filing for Q2 2024, filed 14 Aug 2024.